The Schizophrenia Caregiver Quality of Life questionnaire (S-CGQoL): Development and validation of an instrument to measure quality of life of caregivers of individuals with schizophrenia

https://doi.org/10.1016/j.schres.2010.08.037Get rights and content

Abstract

Objective

This study aims to validate a self-administered, multidimensional QoL instrument based on the point of view of caregivers of individuals with schizophrenia.

Methods

Data were collected through the departments of six psychiatric hospitals in France (n = 246). The item reduction and validation processes were based on both item response theory and classical test theory.

Results

The S-CGQoL contains 25 items describing seven dimensions (Psychological and Physical Well-Being; Psychological Burden and Daily Life; Relationships with Spouse; Relationships with Psychiatric Team; Relationships with Family; Relationships with Friends; and Material Burden). The seven-factor structure accounted for 74.4% of the total variance. Internal consistency was satisfactory; Cronbach's alpha coefficients ranged from 0.79 to 0.92 in the whole sample. The scalability was satisfactory, with INFIT statistics falling within an acceptable range. In addition, the results confirmed the absence of DIF and supported the invariance of the item calibrations.

Conclusion

The S-CGQoL is a self-administered QoL instrument that presents satisfactory psychometric properties and can be completed in 5 min, thereby fulfilling the goal of brevity sought in research and clinical practice.

Introduction

Schizophrenia is a disabling and severe psychiatric disorder with either episodic or continuous evolution that can result in physical, psychological and social problems related to both the disease and the potential side effects of its treatment (Green et al., 2000, Kasckow et al., 2001, Kurtz et al., 2008, Lehman, 1983, Reine et al., 2005). Schizophrenia also affects the functioning of family caregivers, especially because the caregivers have assumed functions that were performed in the past by psychiatric institutions (Caqueo-Urizar et al., 2009, Ochoa et al., 2008, Reine et al., 2003b). The impact of caregiving on caregivers' quality of life (QoL) is important (Caqueo-Urizar et al., 2009, Martens and Addington, 2001). Caregivers of individuals with schizophrenia have reported reduced QoL, especially when experiencing a significant burden (Glozman, 2004, Li et al., 2007), restricted roles and activities, and increased psychosomatic, anxious, or depressive symptoms (Awad and Voruganti, 2008, Schulz and Beach, 1999). Caregivers' negative experience may affect their ability to care for the patients. This is an important concern because involvement of family caregivers is essential for optimal treatment of patients by ensuring treatment compliance, continuity of care, and social support (Reine et al., 2003b, Velligan et al., 2009). Several studies have shown that a lack of family involvement in treatment planning is associated with problems in treatment adherence (Ahn et al., 2008, Cooper et al., 2007, Valenstein et al., 2004). Therefore, assessing and preserving caregivers' QoL is a noteworthy issue both for the caregivers themselves and indirectly for patients' health.

Caregivers of individuals with schizophrenia have received significant attention in the past few years. Most of the research is focused on caregivers' burden (Levene et al., 1996, Provencher and Mueser, 1997, Schene et al., 1994), caregiving (Joyce et al., 2000, Szmukler et al., 1996), coping strategies (Magliano et al., 1996, Roncone et al., 2007, Rosen et al., 1989, Rosen et al., 2001) and opinions on the causes and consequences of mental disorders (Kallert and Nitsche, 2008, Magliano et al., 1999). Although studies have been conducted on specific issues in caregiving, little has been done to explore QoL among caregivers of individuals with schizophrenia, and no QoL measurement scale has been specifically developed for use with this population (Caqueo-Urizar et al., 2009, Li et al., 2007, Martens and Addington, 2001). A self-administered instrument based on the caregivers' point of view and anchored in an explicit conceptual approach (McKenna, 1997) could constitute an innovative area of research in schizophrenia. An exploration and evaluation of the caregivers' QoL could be useful in improving patients' health and QoL, preserving caregivers' health and their ability to care, and developing new care strategies.

We present the results of the development and the validation of a self-administered, multidimensional QoL instrument based on the point of view of caregivers of individuals with schizophrenia: the Schizophrenia Caregiver Quality of Life questionnaire (S-CGQoL).

Section snippets

Subjects

Data were collected from the departments of six psychiatric hospitals in France: Ajaccio (one hospital), Bordeaux (one), La Seyne sur Mer (one), Marseille (two), and Paris (one). The inclusion criteria for the caregiver were as follows: (1) having a family member with a diagnosis of schizophrenia or schizoaffective disorder, according to the DSM-IV criteria (APA, 1994); (2) being the mother or the father of the patient; (3) being identified by the individual with schizophrenia as the main

Results

Only the results of the final psychometric validation phase are reported in order to avoid confusion with intermediate development versions of the questionnaire.

Discussion

In the past, the primary emphases in research have been on the person with the disease and on the disease process, rather than on family caregivers (Carter et al., 1998). However, caregivers are now considered to be a major component in delivering an integral service to individuals with schizophrenia and their families. For example, Caqueo-Urizar et al. (2009) suggest that the development of supporting activities for the family is an important concern, and they warn that focusing solely on

Conclusion

The S-CGQoL is not intended to replace available questionnaires on burden, caregiving and opinions. Rather, the S-CGQoL adds interesting information that is oriented toward a more global service to individuals with schizophrenia and their families. It would be important to explore the reproducibility of the current results and their sensitivity to change. However, reliability and validity of S-CGQoL are evidenced by our results. Our approach provides an original, valid and valuable tool that

Role of Funding Source

None.

Contributors

RR and LB wrote the manuscript.

All authors designed the study and wrote the protocol.

RR and LB managed the literature searches and analyses.

AL, LB, MCS and PA managed the statistical analysis.

All authors contributed to and approved the final manuscript.

Conflict of interest

The authors report no conflict of interest.

Acknowledgements

None.

References (61)

  • M. van der Gaag et al.

    The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions

    Schizophr. Res.

    (2006)
  • M. van der Gaag et al.

    The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model

    Schizophr. Res.

    (2006)
  • APA

    DSM-IV. Diagnostic and Statistical Manual of Mental Disorders

    (1994)
  • A.G. Awad et al.

    The burden of schizophrenia on caregivers: a review

    Pharmacoeconomics

    (2008)
  • M. Calman

    Towards a conceptual framework of lay evaluation of health care

    Soc. Sci. Med.

    (1988)
  • D.T. Campbell et al.

    Convergent and discriminant validation by the multitrait–multimethod matrix

    Psychol. Bull.

    (1959)
  • A. Caqueo-Urizar et al.

    Quality of life in caregivers of patients with schizophrenia: a literature review

    Health Qual. Life Outcomes

    (2009)
  • R.G. Carey et al.

    A patient survey system to measure quality improvement: questionnaire reliability and validity

    Med. Care

    (1993)
  • J.H. Carter et al.

    Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's Study Group

    Movement Disord.

    (1998)
  • CNIL

    Act n°78-17 of 6 January 1978 on Data Processing, Data Files and Individual Liberties (amended by the Act of 6 August 2004 relating to the protection of individuals with regard to the processing of personal data)

    J. Officiel République Française Assemblée Nationale et Sénat. France

    (2004)
  • C. Cooper et al.

    Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey

    Acta Psychiatr. Scand.

    (2007)
  • L. Crocker et al.

    Introduction to Classical and Modern Test Theory

    (1986)
  • L.J. Cronbach

    Coefficient alpha and the internal structure of tests

    Psychometrika

    (1951)
  • J.M. Glozman

    Quality of life of caregivers

    Neuropsychol. Rev.

    (2004)
  • M.F. Green et al.

    Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?

    Schizophr. Bull.

    (2000)
  • J. Gutierrez-Maldonado et al.

    Burden of care and general health in families of patients with schizophrenia

    Soc. Psychiatry Psychiatr. Epidemiol.

    (2005)
  • J. Joyce et al.

    The experience of caregiving inventory: further evidence

    Soc. Psychiatry Psychiatr. Epidemiol.

    (2000)
  • E.F. Juniper et al.

    Quality of Life and Pharmacoeconomics in Clinical Trials

    (1996)
  • L.L. Kaid et al.

    Content analysis

  • H.F. Kaiser et al.

    Alpha factor analysis

    Psychometrika

    (1965)
  • Cited by (39)

    • Cross-Cultural Adaptation and Validation of the Quality of Life Questionnaire for Caregivers of Patients with Schizophrenia (S-CGQoL) in Latin America

      2021, Encephale
      Citation Excerpt :

      On the other hand, while both versions of WHOQOL-100 [30] and WHOQOL-BREF [31] are useful tools for assessing schizophrenia patients and caregivers, these instruments are more generic and are also useful in patients with different medical conditions since they were designed to measure quality of life on an international basis [32]. The literature shows only one instrument that has been specifically designed to measure quality of life in caregivers of patients with schizophrenia: The Quality of Life Questionnaire for the Caregiver of Schizophrenia (S-CGQoL) [33]. This instrument has been validated in Europe, Indonesia and Brazil [34,35], reporting proper levels of reliability (α > .85) and validity (principal component analysis explained 70.9% of the total variance).

    • The correlation between the quality of life and clinical variables among outpatients with schizophrenia

      2019, Psychiatry Research
      Citation Excerpt :

      In addition, the generic QoL scales were developed from the point of view of experts or physicians, which may be entirely different from the views of people with schizophrenia. Likewise, Richieri et al. (2011) reported that the QoL dimension for people with schizophrenia is different from that of other chronic illnesses, due to the very nature of the illness. Information on QoL and its correlates will assist in developing evidence-based intervention that can improve satisfaction with multiple aspects of life among people with schizophrenia.

    View all citing articles on Scopus
    View full text